Pharmaco-electroencephalographic characterization of fipexide hydrochloride

S. Scarone, L. Pugnetti, P. Biserni

Research output: Contribution to journalArticle

Abstract

A pilot electroencephalographic study was conducted on four healthy young male volunteers who received either 200 or 400 mg of fipexide hydrochloride orally in a double-blind placebo-controlled trial. The electroencephalograms (EEGs) from 01-Cz derivation, psychometry, blood pressure, and heart rate measurements were sampled four times at 60-minute invervals during each recording session. Absolute integrated power spectral estimates, psychometry scores, and cardiovascular measurements were statistically analyzed by means of two-way ANOVA. Results indicate that only 400-mg fipexide significantly decreases slow (1 to 4 Hz) and increases fast (10 to 30) components of the electroencephalograchic spectrum after a time delay of two hours from the time of administration. No significant psychometric or cardiovascular changes were observed. It is concluded that fipexide is effective at the central nervous system level and that its electroencephalographic profile resembles that of other dopaminergic psychotropics.

Original languageEnglish
Pages (from-to)933-939
Number of pages7
JournalCurrent Therapeutic Research
Volume39
Issue number6
Publication statusPublished - 1986

Fingerprint

Psychometrics
Electroencephalography
Volunteers
Analysis of Variance
Central Nervous System
Heart Rate
Placebos
Blood Pressure
fipexide
Power (Psychology)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pharmaco-electroencephalographic characterization of fipexide hydrochloride. / Scarone, S.; Pugnetti, L.; Biserni, P.

In: Current Therapeutic Research, Vol. 39, No. 6, 1986, p. 933-939.

Research output: Contribution to journalArticle

@article{1ceacab503714c2a9b7bb7572d649f68,
title = "Pharmaco-electroencephalographic characterization of fipexide hydrochloride",
abstract = "A pilot electroencephalographic study was conducted on four healthy young male volunteers who received either 200 or 400 mg of fipexide hydrochloride orally in a double-blind placebo-controlled trial. The electroencephalograms (EEGs) from 01-Cz derivation, psychometry, blood pressure, and heart rate measurements were sampled four times at 60-minute invervals during each recording session. Absolute integrated power spectral estimates, psychometry scores, and cardiovascular measurements were statistically analyzed by means of two-way ANOVA. Results indicate that only 400-mg fipexide significantly decreases slow (1 to 4 Hz) and increases fast (10 to 30) components of the electroencephalograchic spectrum after a time delay of two hours from the time of administration. No significant psychometric or cardiovascular changes were observed. It is concluded that fipexide is effective at the central nervous system level and that its electroencephalographic profile resembles that of other dopaminergic psychotropics.",
author = "S. Scarone and L. Pugnetti and P. Biserni",
year = "1986",
language = "English",
volume = "39",
pages = "933--939",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "6",

}

TY - JOUR

T1 - Pharmaco-electroencephalographic characterization of fipexide hydrochloride

AU - Scarone, S.

AU - Pugnetti, L.

AU - Biserni, P.

PY - 1986

Y1 - 1986

N2 - A pilot electroencephalographic study was conducted on four healthy young male volunteers who received either 200 or 400 mg of fipexide hydrochloride orally in a double-blind placebo-controlled trial. The electroencephalograms (EEGs) from 01-Cz derivation, psychometry, blood pressure, and heart rate measurements were sampled four times at 60-minute invervals during each recording session. Absolute integrated power spectral estimates, psychometry scores, and cardiovascular measurements were statistically analyzed by means of two-way ANOVA. Results indicate that only 400-mg fipexide significantly decreases slow (1 to 4 Hz) and increases fast (10 to 30) components of the electroencephalograchic spectrum after a time delay of two hours from the time of administration. No significant psychometric or cardiovascular changes were observed. It is concluded that fipexide is effective at the central nervous system level and that its electroencephalographic profile resembles that of other dopaminergic psychotropics.

AB - A pilot electroencephalographic study was conducted on four healthy young male volunteers who received either 200 or 400 mg of fipexide hydrochloride orally in a double-blind placebo-controlled trial. The electroencephalograms (EEGs) from 01-Cz derivation, psychometry, blood pressure, and heart rate measurements were sampled four times at 60-minute invervals during each recording session. Absolute integrated power spectral estimates, psychometry scores, and cardiovascular measurements were statistically analyzed by means of two-way ANOVA. Results indicate that only 400-mg fipexide significantly decreases slow (1 to 4 Hz) and increases fast (10 to 30) components of the electroencephalograchic spectrum after a time delay of two hours from the time of administration. No significant psychometric or cardiovascular changes were observed. It is concluded that fipexide is effective at the central nervous system level and that its electroencephalographic profile resembles that of other dopaminergic psychotropics.

UR - http://www.scopus.com/inward/record.url?scp=0022911208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022911208&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022911208

VL - 39

SP - 933

EP - 939

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 6

ER -